Bas Kietselaer

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski, Bridget‐Anne Kirwan, Stefan D. Anker et al. · The Lancet · 2020 · 723 citations · Full text

Heart Failure, Iron Metabolism, Clinical Nutrition +5

Elevated Levels of Circulating DNA and Chromatin Are Independently Associated With Severe Coronary Atherosclerosis and a Prothrombotic State

Julian Ilcheff Borissoff, Ivo A. Joosen, Mathijs O. Versteylen et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2013 · 426 citations · Full text

Past, present, and future of annexin A5: from protein discovery to clinical applications.

Hendrikus H. Boersma, Bas Kietselaer, Leo Stolk et al. · PubMed · 2005 · 335 citations

Protein Secretion, Engineering, Oncologic Imaging +20

Additive Value of Semiautomated Quantification of Coronary Artery Disease Using Cardiac Computed Tomographic Angiography to Predict Future Acute Coronary Syndrome

Mathijs O. Versteylen, Bas Kietselaer, Pieter C. Dagnelie et al. · Journal of the American College of Cardiology · 2013 · 188 citations · Full text

Coronary Heart Disease, Medical Imaging, Cardiovascular Disease +15

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 142 citations · Full text